The Human Genotyping Unit in the Spanish National Cancer Research Center (CNIO) was established in 2003 as part of the Spanish National Genotyping Center (CeGen)
Currently, the Unit is part of IMPaCT-GENóMICA, one of the axes of the IMPaCT Programme, the Precision Medicine Infrastructure associated with Science and Technology, created by the Carlos III Health Institute to facilitate the effective implementation of Precision Medicine in our National Health System (https://genomica-impact.es/quienes-somos/infraestructura-impact/)
Its participation in this and other programmes and consortia (CIBERER, BCAC, CIMBA, TECAC), along with established collaborations with other institutions, strengthens its role in genomic research at the national and international levels.
With 20 years of experience, the Unit specializes in implementing advanced genomic technologies, such as hight-throughtput genotyping and next-generation sequencing, which are essential pillars in current genomic research, enabling efficient acquisition of large-scale genomic data at a reduced cost.
The Unit provides comprehensive support to researchers in their research projects, covering various stages of the process. This includes experimental design, sample extraction, genomic analyses, and secondary bioinformatic analysis of sequencing data.
Infrastructure available in the Unit includes two Illumina’s sequencer (Novaseq X Plus and MiSeq), a Illumina’s microarray scanner (Iscan) and four automated robots (Beckman y Tecan)
Location and Contact
Laboratory 207-EA
National Cancer Research Center
c/ Melchor Fernández Almagro, 3
28029 – MADRID (España)
Tfn: +34 91 732 8000 (ext. 3351)
cegen@cnio.es